High-dose rate interstitial brachytherapy using two weekly sessions of 10Â Gy each for patients with locally advanced cervical carcinoma

Our clinical results have shown that weekly HDR-IBT schedule (10 Gy × 2) is associated with low toxicity, decent local control, and survival rates thereby proving its clinical feasibility.